Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 9, 2007, Pages 1113-1121

  Jacquemard, F ^a   Yamamoto, M ^b   Costa, J M ^c   Romand, S ^a   Jaqz Aigrain, E ^d   Dejean, A ^b   Daffos, F ^a   Ville, Y ^b  

^a Institut de Puericulture   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c AMERICAN HOSPITAL OF PARIS   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Cytomegalovirus; Fetal therapy; Foetus; Infection; Valaciclovir

Indexed keywords

VALACICLOVIR;

AMNION FLUID; ARTICLE; BRAIN DAMAGE; CLINICAL ARTICLE; CONGENITAL INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; FEMALE; FETUS; FETUS BLOOD; FETUS DEATH; FOLLOW UP; HEARING IMPAIRMENT; HUMAN; INCONTINENTIA PIGMENTI; INTRAUTERINE INFECTION; MICROCEPHALY; OBSERVATIONAL STUDY; PREGNANCY; PREGNANCY TERMINATION; PRIORITY JOURNAL; RANK SUM TEST; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VIRUS LOAD;

ACYCLOVIR; ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; FETAL BLOOD; FETAL DISEASES; HUMANS; PILOT PROJECTS; PLATELET COUNT; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SELF ADMINISTRATION; VALINE; VIRAL LOAD;

EID: 34547842789     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2007.01308.x     Document Type: Article

References (40)

1. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001 344 : 1366 71.
2. Ross SA, Boppana SB. Congenital cytomegalovirus infection: outcome and diagnosis. Semin Pediatr Infect Dis 2005 16 : 44 9.
3. Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 2006 35 : 216 20.
4. Ross SA, Fowler KB, Ashrith G, Stagno S, Britt WJ, Pass RF, et al. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr 2006 148 : 332 6.
5. Gaytant MA, Steegers EA, Semmekrot BA, Merkus HM, Galama JM. Congenital cytomegalovirus infection: review of the epidemiology and outcome. Obstet Gynecol Surv 2002 57 : 245 56.
6. Revello MG, Gerna G. Pathogenesis and prenatal diagnosis of human cytomegalovirus infection. J Clin Virol 2004 29 : 71 83.
7. Lanari M, Lazzarotto T, Venturi V, Papa I, Gabrielli L, Guerra B, et al. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 2006 117 : 76 83.
8. Ville Y. The megalovirus. Ultrasound Obstet Gynecol 1998 12 : 151 3.
9. Nigro G, Mazzocco M, Anceschi MM, La Torre R, Antonelli G, Cosmi EV. Prenatal diagnosis of fetal cytomegalovirus infection after primary or recurrent maternal infection. Obstet Gynecol 1999 94 : 909 14.
10. Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP. Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 2000 137 : 90 5.
11. Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002 15 : 680 715.
12. Boppana SB, Fowler KB, Pass RF, Rivera LB, Bradford RD, Lakeman FD, et al. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 2005 146 : 817 23.
13. Istas AS, Demmler GJ, Dobbins JG, Stewart JA. Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis 1995 20 : 665 70.
14. Jacquemard F, Dejean A, Daffos F, Ville Y. Correlations between ultrasound and fetal haematological parameters in 67 fetuses infected with cytomegalovirus (CMV). P09.01 Ultrasound Obstet Gynecol 2005 26 : 429.
15. Kalil A, Levitsky J, Lyden E, Stoner J, Freifeld A. Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 2005 143 : 870 80.
16. Nigro G, Scholz H, Bartmann U. Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience. J Pediatr 1994 124 : 318 22.
17. Kimberlin DW, Lin CY, Sanchez PJ, Demmler GJ, Dankner W, Shelton M, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized controlled trial. J Pediatr 2003 143 : 16 25.
18. Puliyanda D, Silverman N, Lehman D, Vo A, Bunnapradist S, Radha RK, et al. Successful use of oral ganciclovir for the treatment of intrauterine cytomegalovirus infection in a renal allograft recipient. Transpl Infect Dis 2005 7 : 71 4.
19. Beutner KR. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. Antiviral Res 1995 28 : 281 90.
20. Bell AR. Valacyclovir update. Adv Exp Med Biol 1999 458 : 149 57.
21. Emery VC, Sabin C, Feinberg JE, Grywacz M, Knight S, Griffiths PD. Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. J Infect Dis 1999 180 : 695 701.
22. Lowance D, Neumayer HH, Legendre CM. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med 1999 340 : 1462 70.
23. Strippoli GF, Hodson EM, Jones CJ, Craig JC. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev 2006 CD005133.
24. Piiparinen H, Helantera I, Lappalainen M, Suni J, Koskinen P, Gronhagen-Riska C, et al. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients. J Med Virol 2005 76 : 367 72.
25. Hodson EM, Jones CA, Webster AC, Strippoli GF, Barclay PG, Kable K, et al. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet 2005 365 : 2105 15.
26. Picone O, Costa JM, Leruez-Ville M, Ernault P, Olivi M, Ville Y. Cytomegalovirus (CMV) glycoprotein B genotype and CMV DNA load in the amniotic fluid of infected fetuses. Prenat Diagn 2004 24 : 1001 6.
27. Penna L, Bower S. Hyperechogenic bowel in the second trimester fetus: a review. Prenat Diagn 2000 20 : 909 13.
28. Malinger G, Lev D, Zahalka N, Ben Aroia Z, Watemberg N, Kidron D, et al. Fetal cytomegalovirus infection of the brain: the spectrum of sonographic findings. AJNR Am J Neuroradiol 2003 24 : 28 32.
29. Boulieu R, Gallant C, Silberstein N. Determination of acyclovir in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1997 693 : 233 6.
30. Senat MV, Fischer C, Bernard JP, Ville Y. The use of lidocaine for fetocide in late termination of pregnancy. BJOG 2003 110 : 296 300.
31. Boppana SB, Pass RF, Britt WS, Stagno S, Alford CA. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 1992 11 : 93 9.
32. Stagno S, Reynolds DW, Tsiantos A, Fuccillo DA, Long W, Alford CA. Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections. J Infect Dis 1975 132 : 568 77.
33. Griffiths PD. Tomorrow's challenges for herpesvirus management: potential applications of valacyclovir. J Infect Dis 2002 186 : S131 7.
34. Weller S, Blum MR, Doucette S. Pharmacokinetics of the acyclovir pro-drug, valacyclovir after escalating single- and multiple-dose administration to normal volunteers. Clin Pharmacol Ther 1993 54 : 595 605.
35. Tyms AS, Scamans EM, Naim HM. The in vitro activity of acyclovir and related compounds against cytomegalovirus infections. J Antimicrob Chemother 1981 8 : 65 72.
36. Kimberlin DF, Weller S, Whitley RJ, Andrews WW, Hauth JC, Lakeman F, et al. Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy. Am J Obstet Gynecol 1998 179 : 846 51.
37. Liesnard C, Donner C, Brancart F, Gosselin F, Delforge ML, Rodesch F. Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol 2000 95 : 881 8.
38. Enders G, Bader U, Lindemann L, Schalasta G, Daiminger A. Diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 2001 21 : 362 77.
39. Nigro G, Adler SP, La Torre R, Best AM. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005 353 : 1350 62.
40. Peckham C, Tookey P, Logan S, Giaquinto C. Screening options for prevention of congenital cytomegalovirus infection. J Med Screen 2001 8 : 119 24.